Lv11
30 积分 2026-08-17 加入
Targeting MET in EGFR-mutated NSCLC
2小时前
已完结
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
2小时前
已完结
Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report
3小时前
已完结